C P Cannon|E Braunwald - JoVE Visualize

Showing results (121-130 of 365) with videos related to

Pageof 37

Sort By:

The American Journal of Cardiology|November 18, 1991

Patency of the infarct-related coronary artery and ventricular geometryG A Lamas, M A Pfeffer, E Braunwald

The American Journal of Cardiology|November 18, 1991

Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE InvestigatorsL A Moyé, M A Pfeffer, E Braunwald

Clinical Cardiology|February 4, 1999

The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery diseaseM J Tanasijevic, C P Cannon, E M Antman

Clinical Cardiology|September 24, 1999

Prehospital thrombolysis: an idea whose time has comeC P Cannon, A J Sayah, R M Walls

Circulation|February 19, 1998

Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial InfarctionC P Cannon, C H McCabe, S Borzak, et al.

JAMA|December 26, 2001

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trialD A Morrow, C P Cannon, N Rifai, et al.

Circulation Research|July 1, 1978

Initial myocardial adjustments to brief periods of ischemia and reperfusion in the conscious dogM Pagani, S F Vatner, H Baig, et al.

The American Journal of Geriatric Cardiology|May 22, 2001

Ischemic preconditioning: implications for the geriatric heartR A Kloner, T Shook, C P Cannon, et al.

Journal of the American College of Cardiology|November 1, 1985

Inotropic stimulation of reperfused myocardium with dopamine: effects on infarct size and myocardial functionJ M Arnold, E Braunwald, T Sandor, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1982

Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive ratJ M Pfeffer, M A Pfeffer, I Mirsky, et al.

Pageof 37

Showing results (121-130 of 365) with videos related to

Sort By:

Pageof 37

The American Journal of Cardiology|November 18, 1991

Patency of the infarct-related coronary artery and ventricular geometryG A Lamas, M A Pfeffer, E Braunwald

The American Journal of Cardiology|November 18, 1991

Rationale, design and baseline characteristics of the survival and ventricular enlargement trial. SAVE InvestigatorsL A Moyé, M A Pfeffer, E Braunwald

Clinical Cardiology|February 4, 1999

The role of cardiac troponin-I (cTnI) in risk stratification of patients with unstable coronary artery diseaseM J Tanasijevic, C P Cannon, E M Antman

Clinical Cardiology|September 24, 1999

Prehospital thrombolysis: an idea whose time has comeC P Cannon, A J Sayah, R M Walls

Circulation|February 19, 1998

Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial InfarctionC P Cannon, C H McCabe, S Borzak, et al.

JAMA|December 26, 2001

Ability of minor elevations of troponins I and T to predict benefit from an early invasive strategy in patients with unstable angina and non-ST elevation myocardial infarction: results from a randomized trialD A Morrow, C P Cannon, N Rifai, et al.

Circulation Research|July 1, 1978

Initial myocardial adjustments to brief periods of ischemia and reperfusion in the conscious dogM Pagani, S F Vatner, H Baig, et al.

The American Journal of Geriatric Cardiology|May 22, 2001

Ischemic preconditioning: implications for the geriatric heartR A Kloner, T Shook, C P Cannon, et al.

Journal of the American College of Cardiology|November 1, 1985

Inotropic stimulation of reperfused myocardium with dopamine: effects on infarct size and myocardial functionJ M Arnold, E Braunwald, T Sandor, et al.

Proceedings of the National Academy of Sciences of the United States of America|May 1, 1982

Regression of left ventricular hypertrophy and prevention of left ventricular dysfunction by captopril in the spontaneously hypertensive ratJ M Pfeffer, M A Pfeffer, I Mirsky, et al.

Pageof 37